<p><b>TABLE OF INTERACTIONS WITH</b></p>

<p><b>ANTIPARKINSONIAN ANTICHOLINERGICS</b></p>

<p><b>From the French ANSM drug interactions document of September 2016, p. 27</b></p>

<table cellspacing="0" cellpadding="0" border="1">
<tbody>
<tr>
<td valign="top"><p><b>ANTIPARKINSONIAN ANTICHOLINERGICS</b></p>

<p><b>CLASS CODE: N04AA-001</b></p></td>
<td valign="top"><p><b>DOPAMINERGIC ALKALOIDS OF ERGOT OF RYE</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>G02CB-001</b></p></td>
<td valign="top"><p>Risk of increase of neuropsychological disorders.</p>

</td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Regular clinical and biological monitoring, especially at the beginning of the administration of these substances together. </p></td>
</tr>

</tbody>
</table>

